Drug Profile
DP 107
Alternative Names: T 21Latest Information Update: 29 Mar 2001
Price :
$50
*
At a glance
- Originator Trimeris
- Class Antivirals
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 29 Mar 2001 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
- 30 Jul 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 12 Jun 1995 Preclinical development for HIV infections treatment in USA (Unknown route)